semaglutide by novo nordisk Diabetes Treatments FDA adds warning for intestinal

Baby boy is due in June, she wrote

preconception planning is important for patients with Hashimoto's disease [1] [2] Severe GI disease : Use caution or avoid in patients with severe gastrointestinal disease, including gastroparesis [1] Renal function : Monitor for dehydration and renal impairment if significant gastrointestinal adverse events occur Medication interactions : Do not use concurrently with other GLP-1 receptor agonists Patients with Hashimoto's disease considering tirzepatide should undergo comprehensive evaluation by an endocrinologist or physician experienced in managing both thyroid disorders and obesity pharmacotherapy

Or you may have as directed by the physician

J Clin Invest [Internet]

Your clinician or pharmacist can advise whether to take it when remembered or to skip and resume your normal schedule